<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Choosing a second diabetes agent: Adults with type 2 diabetes taking metformin with A1C &gt;9% and eGFR &gt;15 mL/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Choosing a second diabetes agent: Adults with type 2 diabetes taking metformin with A1C &gt;9% and eGFR &gt;15 mL/min/1.73 m<sup>2</sup>*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Choosing a second diabetes agent: Adults with type 2 diabetes taking metformin with A1C &gt;9% and eGFR &gt;15 mL/min/1.73 m<sup>2</sup>*</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAjoAAAGLBAMAAAA8GCW+AAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAKlBMVEX///8AAADm5uaIiIgcHBy/v79ERETW1ta7u7ucnJxgYGAyMjLu7u51dXVzzKYpAAAgAElEQVR42uyb32/b1hXHj0BVP+gY8LEV/hCth9KJE9sQIGGCUMwYIFrGZHXpQ4LuYdgLZbXNljSAmBjBurSAZHvLgL2IibAk3QZIbVF3XgtYTrEuQQYoqNEMSwZYbrB0Cfq/7FxScvzbShx7jswDRKYudSXyw+/58h7eGwAnnHDCCSeccMIJJ5xwotVw4S5E1xY/+MpP919sTmc3kG9JR913cdSh49Bx6Dh09iWd7Ko9vi7waj/Axrv4Jp+Cdft3RmcAt9hpjLd4ulXxhdHxYNE+67V04p363XyjMe6JNOm48tQtX1hNhv4VWqUz8AmONY/M7G5sZJYadMJCo2Uo1GxsRv3Khmdndi/3sWMwtLx5rI7fM+ImIvuuY9qkqoYRk6qK3a1pJwsb0wE+YiwTeErH6pbfgXbo4P+zjs567QyF1mIYVTehs6ZhSF75JU8sOvNvssYMTrLfH8DzfdjTIh1vNQh+lM9imcc78eiv8Q7ANHbFCXgwy6GY9Iq0beYLNeCxx3W5GqygyY0qtSjqbF8nijHtToG1VDCyLZ1XJVU9nlEm63/D3yF+IWQuoTKZeYR1QY1igHRQwdOIpzMoZpZ+i38PKxnpeIYu/UBIrX8ZOFX9ZD6Gbx/N4H9JD2Z3QUL8XlDruGSEcJx0QRrD8RieHgr+hDbHbeLm/JBFg9EJh1Q81Y+CehEF2t6ODjdnaeIdnzhcuxnL0wtAkjLLEylA1sgDI+CJ8OVZgFgu65qaY5nFpRauyZxFx1WE2Ptp1nI15dmeToGutSGdFOvz9XHKCsTzan2E6FzD64H3KLP6mWj6gyyzHuFv8AMlLBxhF37wsFqhLlW8JYSFCdYy0UN0RJZZYWEwZMiGXJ+3BDMQ6FOGULET1qZz0vIizdJOn6KelPEU7Rzcno63csvKLK9YwWAc6AW8YpNOCRp0fCkRYJZ853LlFqOju28kbDqc9nkc0qzlw3KLdKIjQz318fq82T0oqH0Z7CYQk/jn4ABpxzisqg9RYHS+DajVHwlh5Qh+QZobJykUuqtLg1StmCPMU0JNOkd6BgKG9KocVb5jdAaDx/DnIcvOEG3fUa4w/aHtO/P0TdWlivCoJd+JAZxjdIZr5CD0QkS4p9o5wxGdRThbpg8+SJLnxFxFxuKayOtsH0C6QefqiYXWMuspHcokUzJHmnTQohNWPlhF5+gT/IiZcoXERnSCdLojaj99ZC2dcAVPraRTHx+w6czbHmNrx+xRNcSRcCbQwj3rKsoApkx0eJTj5C3srdKgQ75TUMS4H4smWfH9QNI1hTJPvqO7i5WAzvYtkFvZdP5UDWxPJyycj1uZ1dSO2V23tXMj0GdnFr2wP3ZmER1VrXykfslOtkLXfAAn/0CZNRSaCJ08bD7NLKKjHrXoWJnF6EyEVtOxfWcw8DM8dVJW+wLb+06rEV/fxJfXtiwUtx/vPMQxy5WJTj9z1H6s2nSuVBSic6yCb1cVYaDpykTHQOH8cTqRiiacry6pwxg6zlx5NDSIFbG/6cpEp85u1sSFuTKjQ9/1xgBSBtp0MsyLyGuqt+lXg1X8xQuj402va8oouTUtKOzaWDks2bcgp5LYKI7Q5a84dF6iKtS38akWtqi52o/OKsf1jq2mI63cR+NqRofTl+k0+vrZre4A0IlKm9PxLxq5NdpZ7htrhc5L+FzZi4Lk66VC6xKye7TEWpR/KoEclVs0/hF0z3f0JhpgYO7mwKchp1ewaHWYwSD1KlGBVWqFzv6beXilBe3M8uUzXnHWm4KGWIzrkqectLTjFY1fifxMqpOhOwfgjrDM4ufsDtTXm6LWf6Xal860kcuCrFnmwbSTwetd/IxoZ1b2sa+LSyMmaLRMhIwc0Ylhwu4QB3r5vZAzcu1KZxg8tyHrF2etd0SHn7tLdMpUbgHIMJ3ydXXMMG342JjQHYlyp+XOhN1hGGZXD5vbjs6bQb8EGYxcQirEo2Q+Pk1jdKjcAqiIHboPlRxr55Fe/Fjl9EwgYXeYIN8RM4E21g4AGUl2048t5H1dL2g0+HLSmShuQecJHHA6e1VJbNWR07MOHRZp74+3p9OY5uA0pZgG5nz05iZ7EkCDK7PcnnRczPnTC+WW6cTynWWiI3qoS6GHGmR/L7xzol3pHAZI3gZXVfZp6Y4I8N+OKjW6EQaJDocpV+kzDd2RhSJoAQ++SySZ1ogOl2hULzKX8IrpQ5lAu2pHS4ErEnNHSv8un3FfSLFHimB+rWcnco9dZfdiwZ8oMe3EHtwEr8ShpZ37f6HhKKODSp6bi/t62zaz3vhrzZUvGTnXe+nhEntGDf4qXtCzJgZceRqLHxq7xejMwg+Zbviy5Tu1pnYmim7EXD2523T2fO1X05X5OaLjjsRqoxdet+i4F80LTDvgytNYHIYpjQq12AMi8LBo0RGXnwvI/lSh5lkEI7e7dFoP14uVcRrO3s2XyHfg00OyRYdD7QLznaAr70cN7kbYDIjlO+yepaFk0SmwWk+G2Bnwj2EQ2pTONhGD6dr/f7yzP+lwOAb/AIfO/q4kHDoOHYfOAaDj1SIOHTagA5NNiVnTYk+jU9+4V5YtV1y3HG8P6ex41NzyoViVBNGxq/JVe/nIZnRgt9i0SGdvtNWs0S3t1NHAmWqIywo61QU0cDYxB2exbGI5pt3hUMy+dQnLFbyBcraCxuVq8CDQEdkDLOR0mbTDlyemxrwilUxUsH9D2jnjFcHfG3s/beThbI5NsPFzdmZNzcEBoWNpJxb8miosz1Udso/ZLJnrYoRlkfxHFOOQLrFtDWVr4ozRuczWN7Y7nRWu7L46x5eNKR2mU2yWLMa0k/WLb/gZHdJOFmbBK3cmzhGdIluweIDovKsp9zTmOzp0kDuT77AVqxmMRAOMDvMdsKbKEqac5dGYWl7lse/u6Lt7KAv5lfenl2+8s7uH8gQcOu1bSTh0HDobReecV9zRD3BBSLYtnUPJjsWd0dGKO6PDlXezktrhBZt+eK8a9Gs9z00neSLJ4VfPcCj+Zslkr8l051fTkTb9JZ1NJ2f3lA4vUblz8fn1w514PWnkPn2GSsLzVm0lnWloUTusqM/usXZ8XW7E69XTz00nEe0pWafYao1uTBRpLCz5U9aKVfgYomhUZS4rZgS21lXiMQHcqHKvufQ1Hk+RujFo4Me/pIr9GzattXd0eEp8mH1+Ou6eZ9POMKcbea/kT1grVg/1eiU2r86NcSfuvyZ5ylIsxxS5EGksfQXPV6TuHJtqtzKrUNtT7XireBFTz0/H39Oy79irDFAsgU2HynCu7E9QZpXYAw3uM7pU0qyVRZ6ZxtJX8ERI3TfYVLtFpzMQaePxjq8XzlENLnsS1orVjiLTDqNDenmN0bG0o0982Fj6Cuz/pVpT7XOcThU77HAIsr/p0KmWyHeiyv/YO7vXNrIrgB8xyoxmLINOLTwjy4HtfzACo23jFwkFFHUT6J8goyVpXAyjjXBSuwUP+CFL+iARkY/uPsh4ye4qu2CR0mWLCwprutDtgxcChZT+L73njmwpjqQolr80c86L7Ju5lvTLufeeM3M+MjJitUKBrmWiA2LfIToq7Ts41wl9FfuOLbT7DmbvZreLwmN3ZUx+QGzl/w08n9iTGHZ6Mx3+SBNO54zvnDIdpnMSdI6kCL4h6uwFoKM5IfhkjHcYef7BR0GMHZ5Mh3Qoett98/p6G5QEpKrCtl6yhf2o9trI08K6f9l1uLTWXITC4E+cTnS29mic8N+R53ef9g3QnSN0xKiShGy1APCx+csjdAynCYvdFF99v3zPC/k+6ZW1heNZn6PO7z5Hp8zTeHzrstCdensRgEr46NkZGd/uunJoHf+DCeGqf7pEdJZvCt2RdYD+2Zrr5Da/hlyTlOZyxCLeL++Z041ToFNGdMahM+r87nN06X6HizVBJ0xfnkr4qPtefLtry6Gmdo10J9es0cpadlMb0t9qqo3yGnnsEMlH5jfbwi+p3Jd37lbEyvrmFOioON72N+r87sqSmacq5d+WlNsZWkMFN9K6JePbXZBDBbhNdPLxkNQdA4lOJG+qdqiOVK6s7hj0Gq6qT2gb+6kRMaM3ToGOPuZT2FHnd58Uy8xTj070I9ujI9RFxre7IIeamkV0MtseHY3oUB0g1a6t0QJSd2GvquwI3Snfj8mcVUEndwp04PAMOaaMOL9LR7rfHh141fboqJiX8e0CEw2t476kAyG5smBrA2QdIBVnhMfu0HKu070M2nfE2ws9+up0VhakxrydNOL8/h+lNNLQ4TGmntytrxHplD8Y7z1GnN/3o+jzowwdWDWFc6Bz6Qzeg330yaZzvGDSE8njmgA67300hU7CRz38G0yH6TCdU6FzsWs3nTOdCy4nRmfY85SjASaRWNrndAxMbvR+3zfpdH9PB5NOwzCH0em5mxdIOvCtgt8pmKfgmTDmqDh33OlE2exhrrhJVeS+pCzxpPCksZGLFsSQvAkYBDrpsvOs4rym4BmhO/m9x1RFrhNlI3SpoGduRqjcMswoGcqTUTJiiDzUJ4HQnTps1jBOwTO0ssJPqYrcQZSNcgvRLGmSjqVnPkNz78FjMeTdBAzCviN1B+iGU2SeinPn4TDKRvxeAFnf26NzQzeNq20qDiNvAgbgzHLkvjNHwTPRVq4YrlIVOS/K5vMW7TsZQacyJ+mk4qY2A2LIuwmYDpi9M4rdE1xrkOmwJ8F0ToiOV2rg4GmBa3WMYKYjf6RSA90khRfQS+dg+6l5LZUCSIdKDXTpXIO+ujMwCMLXdLxSA16vpHVZLTdPjyDTYvylA+GHReFcraMFeiDpdEoNyF5JsoQ35eXcj6XF+E8fFipKUThXz8GKfuEEkc5hqQFhD8sS3pYMfRCeaehPzfoVpSgM5AJVOYdg6o4sNSB7JclkHEuGPgjdWfjxqpGTdJqaFdAzq1NqQPZKkiW8Le1g34Gcbko6lXhQdWckGZb6Eng67rCIT9Yd9rOYDtNhOuPQ+RmLg+mUAkvHC8vT0OpLZwl7b2O8RwLexNAJUWA6+dfpQxg9OS6qTRbvpbfpTOEMwLIsku1r3bF6gLwVwdkZSA2gA4XNeJVyG8obdTWdo0ZafqOjtuYiJs6lDUzU8CHl6adVWSikBk2hO26LnPD+dHQzp1+n3Aai851spOU7OkX3nreynqt2xXlNdIru6j506GwsD6KzhI9NMCm3gejYspGW7+jYZUlHycZVu4Zx2QK9fK91q0OHKgz035WXqYnxdcptCFU/FnSokZYv6SxCulx9pe7T019Jx4Gme/fv76RD+w68aiv4V9KdpbjP6IRwlehU5tIqXtXFvjPn0VnFvBp/B51jWzxBspX1eabDngTTYTpM58LQGVZ/IMh0en30dMclG8lR9zudt3x01p3BPrqCs6qdxOrPeGcURz0YdHp8dLGyZpQMlfYfwVEPBJ2uj16nfceKmFTafwRHPRC7ctdHLzvPBB3hoYcfjuKoB4VOx0c38G+qjfE/Z5M/jOKoB8oa7PjoFp9ZQ3x0psOeBNNhOkznwtDplGJ3mU5HoqZuypBky6NDXjrTOfQkXkznDqvWMZ2jdF5PXZmyU7Js/0yolaC8CFdrXdZasrh/0OlU9vZe3s1PU+n1UshekLpDzfd2YJF1B0JXphZ1xIzVpGZ6dUknXFUfb32/lqwG/swyctM3ZJrEwr9zRGdf6k6ZmuoNrzEaCDqKqScghQ3rJyQ6emffUTCRQtadrkQLbA0OpBPyoi6ZDnsSTIfpMB2mw3TOQc65zmlAJQQsTIfpMB2mw3SYDtNhOn7++uMZyjFWjpP075gO02E6TIfpsLCwsLBMgkzvDCuV925JNcK2f+lEc1P748xfSPiZDmy++lHWnzkunYU9O5V0/ErHoIK4q8fWn4W9Lz40jaJf6URiYcQnrVvHpaPgrzORjH/pGA3x0jwuHcj6W3e0Fq5SAaxj0qn5ed9hYWFhYWGZIOE7p0yH6Zy8aE4IPjn+9LsQ0z7wL53obO3R/PGnv7ydWGr7WHm2cHjW53AxkIqF+lfKiGN4kRq1VfWxqDg7zvSl90zmmjDRqSnU8aU2YnnzSRUc60wO+TwPIGWPM1uZ8Ted8lj2ivYLf9O5NN7037Kn6n9X/LwSuHzqbJ5M8l+I6TAdpsN0mM7Z0fFaqw+pcB4sOgmoHfwYiXmt1cFlOv3pGNJLYzpdOlprTsc5pYSYgRqWcVfoTk4z06k13A04HWH9Go2KA7UfrpHuqDZoCY/OwsZi+wXrThjxaQvvFD06q9ihk4atPjeZA0fHaEB4vybozBOd51Gis6wIOotteCsQLID7Dt7B7J1itJURdDbjRMdNCjoGJsIbbO8MlkdsDbKtzHQGSDnDdPpIp5XEonWEjtv7r107GY70VeiMTS4d+VxXHDHS9Pe+bo8XUPIqlheaR+n0XF7yXgUJgnGETnqy6XhfvwOk1F939Ou19mDdKflYd0IbC9ldt4zbxS18iolU3BGofo+NdfzS0jOl0P1k3FE7SVcHdCJZVKiPlrzsa0yUFKGBkVjlV7F1pLbQCubr7UWATYylp9Fcx0YNG3W0t5LtyaPzx4K3soydkpafbgg6NyPmImgeHUttlB2vnvIBnbDtysuXNbOp5cXKKgsFjJjCzXoG1Ba64rwOVwsAObGyQlUQ14A+vwLK7pQ9cXTS4NFZwEyJSnELOiXNXEs+9ujEjEYK0eqlU3Zc73JIZIXmQKlOqyi+H4kVgFr71jCu3M6AZgo6SvYbcc1naD6YXfMCgyaQzo7sYL1Cpbg9OqBkEmqHzlF7J2yn5OUl3RTb9UpHdyyhKk2N6AiHPfqRTd23aFemLf2GboKxvQvwbNLOLKKjZbepMVYtkcKGRyeF1VRyAB0dW7Lh9RLa62jWDvedr2KVJNFRhGf+SmwxtWQsvYe74ppU3FyKO2Krusa2ct/jzzv9ikwHhjbGZjrshTIdpnNydKYTMI1z7Tp+b0H4CiY3yv0in4NKZ+8m1J31PyRguwnuvxqGCf3KRgSOTirpJH4DUC879Q0w9sVP7aYwk75lOkI00yjSk5kV1VZaObUqrOnPrwk6aVioMh09E8lYMglAOKuVv4i9ZvrrjNSdAu/KUncEHWUnWrjSrnw6A9ta0jZo3+Ezy9t3LHJOofkAZ2ABfwctx8Ckw7rD9g7TYTpMh+kwHabDdC4uHc6xOQeJAQvTYTpMh+kwHabDdJiOHwTPUGKsBb7SOKbDdJgO02FhYWFhCar8F8rOmb3ZxHVO2rP/cXZvNnGdkyI3rq/LpKozoTNxnZO2NppafuWMdGfiOie5kMXEg9kz+Q+dvM5J7v/bO7/fJpIkjrc1oxnbJJJLzMXjBP6HibAMC/tgy4iJUZDuT3AUxIrsItmKxZGwDx4R7cPePdiKRTh2T7IF4kfYh1hIl1vWD15hcatjH3Lae+L+mauqHv+C2DmWYOykW4oIbk+b+VBT1d/qdhfXQQpXR0Jn4ioneeI20JeqRkNHVU5STTXVVFNNtY/WIkf0sxQdRedTtlFWM5q8ykmjrGY0eZWTRlnNaPIqJ42ymtEEVk4aZTWjyaucNMpqRpNXOWmU1Ywmr3LSKKsZTV7lpFFWM5rAykl/PKKfpdoheMLD+KZVAMapHSKdQxlgrL6qF1B0FB1FR9FRdIY3w5F/Lr/PyO2LDm7LY09nqgaP8zkxzyfEFYpCeLBAB8jtT8fzz66m9h2kw1WcFCwIv3hSDx3sC8Aq5X0CcFKEevM/Pada+6eHjzEdY9d8inTiZhoFExCd3H/pALlBdLp3eVIkiE4pjn+BfjrUJ2wtWXCwv9w0rjYn1HZohyHR4T0tAaazTQfIUXcNztqhZA1Ky3S27qyoWSnL0y7ONWvgCCQjmA69l05PD0PMqOOb/D6i49PLFzjFIU+nC0biqUbv6eHjTKcslmJsO5narKQDX9ABcqS9XYPo0LnfeaA6SS49WZrb2nSxX3c8i+/+IXbKs+WfGVlvtd3HtlPCJ+sf4gJ3+6fTIZ2vM72nh4+57WQ6fofprLnyADm0AKbDB3mLUB3Wq0wnq9+vGmwfFfY78tBr/ElZhpNfb/chHfY7WxmR4tSqfzod1RrI9J4ePs50Tuwynbh8UfqdlztTGd0R2mLLiRkuHeQtuE4S2k6T6GxihwidFnG2HeHTyZf+g3RW231kOzRkqXLrlLgRzrZPp2M6A08PH8eYBTNMh/+zvZxx1RHbhaaYql905ueSSxbR0SCVW7JeW0Tn+7ol41IYwGM6gE+eAReRztd4UTtmSTraJbQkqqYkT6djOgNPD5+Q+c5vQ69uld7z4+4eo7kyzKi5slISio6io+h8Yjp+waghlWgHX/R2W3p7EG+86fwLZv8UlTMeYaLsDoJVFP8uDaNjd0tKmUvwQ4VW1EmBlPsvor4lLpSC/VVRrlLZKjExdAI00f8yt75FBXBQVot5mrRFp3emLmWH0+nOf6rBXaSzEsSRDOi/iPoMh5MAK2ZGXFvcz/7Gmc4f+BB3Lg8k5TXRCVdDbpQKbmWMRBKtakZ38mswy6IBGmG4DFFZcGtGsBAhOnwoM6U5ylBFKd7pQzqUBFgxo2Y0Q9dXwK2gOoXdQOVJKhZMwVjbTihigLSd+2j9RAdmcsYeCSyn8moXb6iYQDqk1LOpmDBj8Rw9WV5xJV9KUHkkiBKdUBQ7OQkUOoVSHC+SfWQ7SGXJcrSdhLSdK60SCrxHgapeqqCmH2s6aDf6VtvvSNup5PJgkYgP3HTIMojOGlU0FuImxLbZ73hiu0JPTxwHYL9T8m3nO67P1OkzHPY7K6/3dJJkWhbdnHY9WREbgWIeIJ8bPZ3+BG9flvJdr/xTjukkRYfOdOMC6Sndib9yCNIjozpfoIrGQjybItuJMR3sEKLwFdNZ6SQQr4SITqePnizBfsdrGntIp9x8YVoO2U5Rp8+YP3Q6cfgRR+5mhPtSuAnD6aHjHUiHYhbAMtOhIdG/XktToob8jkOZv78Hoc4VjYXYsGIGJGtRohOGSzIuleEk0zEghkNYRAcvascsSUd4l0WIKsTdhsviYZP8TjGYskJQP2w62oJ4g3S6GeH+FG4fnYNt5wPa9jjOBpEM/XQzwu0U7hRGmkyiDHfrs8SNgoNn1qFYm/tlzsrNwy30nIdHx4DdcaSTL87Psu20M8KdFO7zwlaSnqyslxOF3BsMDl44G7jTOHHONh7biLRy9JUEktnu+B2m007hvnmarrLfoQjMNRw9vRT4FuBJJPw0ibMNDBtHnc50hul0M8J+ChdddPKhkzD2mE4hJzA4eOFq/k5DBCNhtp3f7XcGrnPKefO+9Wk/kQqlmAXQzQj7KVyawJVziRDcJTrU87Dpmal6sQb3IlRA9FbKepeO3efA/VU9/24TQ+mwu7f5Xb10Eu8M240M+0KeFI3eCW/v2MIw20kcbDsTS4ckE86L6q4Obg3KZn1WuzjXApfiXoLWOMko86/wl6WZXyyrdlq+8BLcABqlMwdbaKTByG3Yuw2P+aJpcoG2l7oMeyi5DPjK8wAK+P56bN/93+NNp7gil4nFFXyywtXCqtu6F9F2eGZJ0e/nNfc8LXYuvj5n69my4BcwJAbuuIZzUkuy7WybCxeEvIhXunDYS6FI/Nd0/NfnnkO2cyXgxMfYdrhi7z50aN7kiThOmpEOOrTNrH4vYtZ+5Hk3erATF+4/4MVO7UnEINlIL2BIDHxbNRw7JOlkxPX1uS2+SEv9wMMu0wrWyrY47+GTxaNXRkTHTDlDnAK+0JdJ8dhHth7mhtB5gQooUELbwUv1e6c4ASHpaJf1qFzsPCfp0AsYEgN3FltE54K0HZvEWpzdUKZDx8yg+Xg8m39BdPZCkRHQ6d03gzDs4XSea9llMfU86A6mA7uogMLkd1CM69/X0ySaJB3Tnk7SL+h3JB16AUNi4C91i+gUfL8zD5t8UQsabTo4JyO/g2INR0c6IfjrKOiEHfEetrNAW2YQ6LOBMcv7ff+ag5ZGE59gvoMKt4yz3g34DGa15ShGDpsjwybHBdpOg3Rot43UV9Y6pK9DbIDtfAidA5dGPwUdSrmguaQpUflyQcPIYXNkoDhC+ZRnBu+jOCP1lTtdtenJGuB3jpqSwPnGBt6/GaW9NavZMEUOjgwUR4oV3k6DT5axLfUVQFLSMXfFcaDTsR3aW5Ol3TY2RwaKI8UKb6dBOoVNqa9c2quWvfER8jvjSQf9DtHZgDOUsaPdNux3SFpR1KTtNCyz2vqKnqxy7LjQ+Wg6qyu0zNSZ/+urL/YH9o87HZzErsqq1r056Onsz8WBswVODmTbsyU/5nkH0fEmjE57LbSUeMd2wk5eDKXz1t17B9vO5NGRa6E0LQmlTvo56KYIplBMw+wGlDZgHv4mv5Nfs9C3scy+m8jQyuiXUL0NNl40m4dGysJfTuMk6591XhypQUn2k3s8Wz+Nw1Ny6SpctXIpa22R9er42w6thZLtGHvCz0E7lH8mxZAJJdNoKv7mUlfgnIpltrFL86zstWD0ET5ZdOKgGcMnC9X9Hbe16d92eEf2U2jFnm/22HauhWwdx9/L6KWJoENroUQnWP/Cz0FXKf980/HoIIco0mHJjXeIcuw8y2zD4XnWMq2M23gRrZAiHb1koLpnmU7py6Tslx9g3MPh8WWUXsbnNagmKhPilX/K6dLvbPs5aE7rs+3Q/zvalOA9zGQ7aZbZhsPzLLx7FOZkO8+mYl6Tr85SvltbRGOaTsp+aTv5Ig7flHQ+O3Wi2no+WTHLANfPQZfQ71hEZwOSJOXi0Cg0aaMA+R2S2XcdjeZZePeFOfY7G1bstfQ7WR1lOinkJSsp+32/g8O/tiSds3WrOr04ifOdAe239xPuzQPf0hf41L7Bt1q5qegcNSWh6LydOe3rfb+NpceAjuf7SZvYSDoftPB7NG2nh46yna7taKm5ehzLHWgAAACbSURBVMw4jxPnPDyQ6ehIYj4n0ma0Ag4Jr2NNx807j9pPFiqlxolzkTiKdaRzQ2gkvI41nWygmOj4Hf0+paNJWyCdP8+sg0z+HHc6MaSzQ1qgwV9SFGJFi4rwg4Zc/DjudGoo2FMPUEdSOproeHNUXgCF1zGmo2aDio6io+goOoqOoqPojBsddValaqqppppqqqmmmmqqqdZt/wO0lOU9IMSzeAAAAABJRU5ErkJggg=="/></div><div class="graphic_footnotes"><p>A1C: glycated hemoglobin (hemoglobin A1C); eGFR: estimated glomerular filtration rate; GLP-1 RA: glucagon-like peptide 1 receptor agonist; MEN: multiple endocrine neoplasia; ASCVD: atherosclerotic cardiovascular disease; GIP: glucose-dependent insulinotropic polypeptide; GI: gastrointestinal; SGLT2: sodium-glucose co-transporter 2; GAD: glutamic acid decarboxylase; IA-2: tyrosine phosphatase 2.</p>
<p>* Insulin or a GLP-1 RA are the suggested second-line medications as they have been shown to have the best glycemic efficacy. We do not typically use an SGLT2 inhibitor in this setting, due to inferior glycemic efficacy and the potential for increasing symptoms from polyuria.</p>
<p>¶ When the diagnosis of type 1 or type 2 diabetes is uncertain, obtain islet autoantibodies (eg, GAD-65, IA-2). The presence of 1 or more antibodies is consistent with type 1 diabetes. Refer to UpToDate content related to differentiating type 1 and type 2 diabetes.</p>
<p>Δ Consider possibility of undiagnosed type 1 diabetes<sup>¶</sup>.</p>
◊ GLP-1 RAs with evidence of cardiorenal benefit include dulaglutide, liraglutide, and subcutaneous semaglutide. Exclude contraindications and precautions prior to use (refer to inset). Refer to UpToDate content for additional information about GLP-1 RAs.</div><div id="graphicVersion">Graphic 135209 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
